Published in Arch Dermatol on February 01, 2011
Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol (2012) 0.92
Illness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol (2012) 0.86
Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psychooncology (2012) 0.85
Health behaviors and needs of melanoma survivors. Support Care Cancer (2014) 0.84
A procedure for obtaining impact of cancer version 2 scores using version 1 responses. Qual Life Res (2013) 0.78
Different aspects of self-reported quality of life in 450 german melanoma survivors. Cancers (Basel) (2011) 0.77
Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study. Qual Life Res (2017) 0.75
Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study. PLoS One (2015) 0.75
A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis. J Skin Cancer (2017) 0.75
Psychological impact of lymphoma on adolescents and young adults: not a matter of black or white. J Cancer Surviv (2016) 0.75
Unrecognized sex-specific stress and behavior differences in patients with melanoma. Arch Dermatol (2011) 0.75
Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick. Cancer Epidemiol (2014) 0.75
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol (2007) 2.59
Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol (2011) 2.45
Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer (2005) 2.25
Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer (2009) 2.08
Polidocanol concentration and time affect the properties of foam used for sclerotherapy. Dermatol Surg (2011) 2.03
Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol (2012) 1.93
Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer (2010) 1.93
Cutaneous malignant melanoma in Europe. Eur J Cancer (2004) 1.88
How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review. J Invest Dermatol (2009) 1.87
A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer (2005) 1.70
Heat conduction from the exceedingly hot fiber tip contributes to the endovenous laser ablation of varicose veins. Lasers Med Sci (2009) 1.69
The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68
Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer (2003) 1.62
Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study. J Invest Dermatol (2006) 1.57
Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer (2012) 1.54
Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg (2008) 1.51
Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins. J Vasc Surg (2011) 1.47
Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy. Melanoma Res (2009) 1.43
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol (2010) 1.42
[Basal cell carcinoma: often more than one]. Ned Tijdschr Geneeskd (2011) 1.39
Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study. J Invest Dermatol (2013) 1.39
Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol (2010) 1.24
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer (2012) 1.18
Endovenous laser ablation-induced complications: review of the literature and new cases. Dermatol Surg (2009) 1.17
Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev (2009) 1.15
Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer (2007) 1.13
Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol (2004) 1.12
Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol (2009) 1.11
Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer (2006) 1.10
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer (2014) 1.10
Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: a study from the population-based PROFILES registry. Patient Educ Couns (2012) 1.08
Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol (2010) 1.08
Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol (2012) 1.07
Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol (2011) 1.06
Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change. Int J Cancer (2007) 1.05
Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer (2013) 1.02
Risk factors for single and multiple basal cell carcinomas. Arch Dermatol (2010) 1.01
Prevalence of multiple malignancies in the Netherlands in 2007. Int J Cancer (2010) 1.01
Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health (2011) 0.99
Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol (2013) 0.99
Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Invest Dermatol (2009) 0.98
Increased consumption of fruit and vegetables and future cancer incidence in selected European countries. Eur J Cancer (2010) 0.98
Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer (2013) 0.98
Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg (2013) 0.98
Carbonized blood deposited on fibres during 810, 940 and 1,470 nm endovenous laser ablation: thickness and absorption by optical coherence tomography. Lasers Med Sci (2010) 0.97
Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans. Hum Genet (2012) 0.95
Epidemiology of multiple primary cancers. Methods Mol Biol (2009) 0.94
Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health (2003) 0.93
Cancer survival in the elderly: effects of socio-economic factors and health care system features (ELDCARE project). Eur J Cancer (2005) 0.93
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases. Acta Derm Venereol (2005) 0.93
Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol (2012) 0.92
Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. Eur J Cancer (2008) 0.91
Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer (2008) 0.91
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire. JAMA Dermatol (2013) 0.90
Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort. J Am Acad Dermatol (2011) 0.90
Re-attendance at biennial screening mammography following a repeated false positive recall. Breast Cancer Res Treat (2014) 0.90
The heat-pipe resembling action of boiling bubbles in endovenous laser ablation. Lasers Med Sci (2010) 0.89
Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res (2010) 0.89
High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer (2010) 0.89
Duplication of the great saphenous vein: a definition problem and implications for therapy. Dermatol Surg (2011) 0.89
Optical-thermal mathematical model for endovenous laser ablation of varicose veins. Lasers Med Sci (2013) 0.87
Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer (2006) 0.87
Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer. Dis Colon Rectum (2013) 0.87
Should the EU also wage war against cancer? And if so, how? Foreword and afterthoughts to this special issue on cancer control at the European level. Eur J Cancer (2008) 0.87
Internet based computer tailored feedback on sunscreen use. J Med Internet Res (2012) 0.86
Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries. Eur J Cancer (2005) 0.85
Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study. Acta Derm Venereol (2009) 0.84
Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer (2009) 0.84
Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer (2006) 0.83
Socio-economic implications of cancer survivorship: results from the PROFILES registry. Eur J Cancer (2011) 0.83
Dimensionality of the dermatology life quality index (DLQI): a commentary. Acta Derm Venereol (2006) 0.83
Patient advocacy groups: let's stick together. J Invest Dermatol (2010) 0.83
Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? J Clin Oncol (2007) 0.83
Population education in preventing skin cancer: from childhood to adulthood. J Drugs Dermatol (2010) 0.83
Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol (2009) 0.83
Scenarios of future lung cancer incidence by educational level: Modelling study in Denmark. Eur J Cancer (2010) 0.83
A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO). Eur J Dermatol (2012) 0.82
Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003. Int J Gynecol Cancer (2010) 0.82
Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarkers Prev (2010) 0.81
Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas. Exp Dermatol (2010) 0.81
General practitioners and referral for palliative radiotherapy: a population-based survey. Radiother Oncol (2009) 0.81
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Med Res Methodol (2012) 0.81
Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project). Crit Rev Oncol Hematol (2005) 0.81
Comorbidities in dermatology. Dermatol Clin (2009) 0.81
Diverging breast and stomach cancer incidence and survival in migrants in The Netherlands, 1996-2009. Acta Oncol (2012) 0.80
Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology. Oral Oncol (2012) 0.80
Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users. Int J Cancer (2013) 0.79
Decreased prevalence of atopic features in patients with psoriatic arthritis, but not in psoriasis vulgaris. J Am Acad Dermatol (2012) 0.79
[Skin cancer epidemic in the Netherlands]. Ned Tijdschr Geneeskd (2009) 0.79
Investigating cervical, oesophageal and colon cancer risk and survival among migrants in The Netherlands. Eur J Public Health (2012) 0.79
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study. Cancer Med (2014) 0.79
Lower lifetime prevalence of atopy in rheumatoid arthritis. Rheumatol Int (2013) 0.79
Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated. J Clin Oncol (2003) 0.78